156 CHAPTER 7 44 Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, Holland MC, Jensen PEH, Jury EC, Kirby H, Kramer D, et al. 2015; Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. Clin Exp Immunol. 181(3):385–400.
RkJQdWJsaXNoZXIy MTk4NDMw